Brodie N H, McGhie R L, O'Hara H, O'Hara J, Rodway A E, Valle-Jones J C, Schiff A A
Curr Med Res Opin. 1976;4(5):346-52. doi: 10.1185/03007997609109327.
A study of 223 patients diagnosed as suffering from mixed anxiety/depressive states was carried out in general practice to compare the effectiveness of treatment with a once-daily tablet preparation containing 1.5 mg fluphenazine plus 30 mg nortriptyline, taken either at night or in the morning, with the same total daily dose taken as 1 tablet t.d.s. Patients were randomly assigned to 4-week's treatment with one of the three drug schemes, and patients' self-ratings as well as physicians's ratings were used to assess symptoms. Both rating assessments showed that there were highly significant improvements in each of the three treatment groups over the 4-week period. Although there were no clinically important differences between improvements in the night-time dose and t.d.s. groups, there was a higher incidence of drowsiness and tablet defaulting among patients taking the single morning dose.
在普通医疗实践中,对223名被诊断为患有混合性焦虑/抑郁状态的患者进行了一项研究,以比较一种每日一次的片剂制剂(含1.5毫克氟奋乃静加30毫克去甲替林)在晚上或早上服用,与每日总剂量相同但分三次服用(每日三次,每次一片)的治疗效果。患者被随机分配接受三种药物方案之一的为期4周的治疗,并使用患者自评以及医生评分来评估症状。两种评分评估均显示,在4周期间,三个治疗组中的每一组都有高度显著的改善。虽然夜间服药组和每日三次服药组在改善情况上没有临床上的重要差异,但单次早晨服药的患者中嗜睡和漏服药物的发生率较高。